Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-16-000922
Filing Date
2016-05-24
Accepted
2016-05-24 16:23:48
Documents
1
Period of Report
2016-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_3976.html 4  
1 PRIMARY DOCUMENT doc4_3976.xml 4 25385
  Complete submission text file 0001638599-16-000922.txt   26782
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Pfaffle Antony (Reporting) CIK: 0001368953 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 161672132

Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07921 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations